Home Cart 0 Sign in  
X

[ CAS No. 455-14-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 455-14-1
Chemical Structure| 455-14-1
Chemical Structure| 455-14-1
Structure of 455-14-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 455-14-1 ]

Related Doc. of [ 455-14-1 ]

Alternatived Products of [ 455-14-1 ]

Product Details of [ 455-14-1 ]

CAS No. :455-14-1 MDL No. :MFCD00064396
Formula : C7H6F3N Boiling Point : -
Linear Structure Formula :- InChI Key :ODGIMMLDVSWADK-UHFFFAOYSA-N
M.W : 161.12 Pubchem ID :9964
Synonyms :
Chemical Name :4-(Trifluoromethyl)aniline

Calculated chemistry of [ 455-14-1 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.14
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 35.85
TPSA : 26.02 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.59 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.54
Log Po/w (XLOGP3) : 2.39
Log Po/w (WLOGP) : 3.45
Log Po/w (MLOGP) : 2.57
Log Po/w (SILICOS-IT) : 2.11
Consensus Log Po/w : 2.41

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.68
Solubility : 0.335 mg/ml ; 0.00208 mol/l
Class : Soluble
Log S (Ali) : -2.58
Solubility : 0.426 mg/ml ; 0.00264 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.91
Solubility : 0.197 mg/ml ; 0.00122 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 455-14-1 ]

Signal Word:Danger Class:6.1
Precautionary Statements:P264-P270-P273-P280-P301+P310+P330-P305+P351+P338+P310-P391-P405-P501 UN#:2810
Hazard Statements:H301-H318-H410 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 455-14-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 455-14-1 ]
  • Downstream synthetic route of [ 455-14-1 ]

[ 455-14-1 ] Synthesis Path-Upstream   1~59

  • 1
  • [ 455-14-1 ]
  • [ 333-20-0 ]
  • [ 777-12-8 ]
Reference: [1] Synlett, 2012, vol. 23, # 15, p. 2219 - 2222
[2] Journal of Organic Chemistry, 2017, vol. 82, # 18, p. 9312 - 9320
[3] Journal of Pharmaceutical Sciences, 1994, vol. 83, # 10, p. 1425 - 1432
[4] Journal of Medicinal Chemistry, 1999, vol. 42, # 15, p. 2828 - 2843
[5] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 23, p. 5561 - 5565
  • 2
  • [ 455-14-1 ]
  • [ 1147550-11-5 ]
  • [ 777-12-8 ]
Reference: [1] Journal of Organic Chemistry, 2018, vol. 83, # 19, p. 12129 - 12142
[2] J. Gen. Chem. USSR (Engl. Transl.), 1963, vol. 33, p. 2240 - 2245[3] Zhurnal Obshchei Khimii, 1963, vol. 33, p. 2301 - 2307
[4] European Journal of Medicinal Chemistry, 2018, vol. 148, p. 477 - 486
  • 3
  • [ 455-14-1 ]
  • [ 540-72-7 ]
  • [ 777-12-8 ]
Reference: [1] Patent: US2832761, 1954, ,
[2] Patent: US2822359, 1954, ,
[3] Patent: US2865909, 1954, ,
[4] Patent: US2857372, 1954, ,
[5] European Journal of Organic Chemistry, 2011, # 19, p. 3421 - 3429
  • 4
  • [ 455-14-1 ]
  • [ 777-12-8 ]
Reference: [1] Journal of Medicinal Chemistry, 2016, vol. 59, # 21, p. 9814 - 9824
  • 5
  • [ 455-14-1 ]
  • [ 26893-12-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 6, p. 1577 - 1580
[2] European Journal of Medicinal Chemistry, 2015, vol. 103, p. 1 - 16
  • 6
  • [ 455-14-1 ]
  • [ 87-13-8 ]
  • [ 26893-12-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 1998, vol. 8, # 19, p. 2629 - 2634
[2] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 8, p. 1487 - 1490
  • 7
  • [ 455-14-1 ]
  • [ 821-48-7 ]
  • [ 30459-17-7 ]
Reference: [1] European Journal of Pharmaceutical Sciences, 2016, vol. 88, p. 166 - 177
  • 8
  • [ 455-14-1 ]
  • [ 400-98-6 ]
Reference: [1] Journal of Medicinal Chemistry, 1995, vol. 38, # 10, p. 1786 - 1792
[2] Organic and Biomolecular Chemistry, 2016, vol. 14, # 9, p. 2645 - 2650
[3] Patent: CN107032965, 2017, A,
  • 9
  • [ 455-14-1 ]
  • [ 49713-56-6 ]
Reference: [1] Journal of Medicinal Chemistry, 2013, vol. 56, # 19, p. 7679 - 7690
  • 10
  • [ 1616514-66-9 ]
  • [ 579-66-8 ]
  • [ 455-14-1 ]
  • [ 1616514-74-9 ]
  • [ 1616514-80-7 ]
  • [ 1616514-86-3 ]
YieldReaction ConditionsOperation in experiment
16% With hydrogenchloride In ethanol for 2 h; Inert atmosphere; Reflux General procedure: To a round bottom flask were charged with an N,N′-diaryl hydrazine (9 or 15, 1 mmol), 95percent ethanol (10 mL), and conc. HCl (0.5 mL) under nitrogen at room temperature. The reaction mixture was refluxed for 2 h, then cooled to room temperature, neutralized with solid NaHCO3, filtered, concentrated. The residue was purified by flash column chromatography.
Reference: [1] Organic and Biomolecular Chemistry, 2014, vol. 12, # 27, p. 4952 - 4963
[2] Tetrahedron, 2016, vol. 72, # 17, p. 2186 - 2195
  • 11
  • [ 455-13-0 ]
  • [ 1639128-66-7 ]
  • [ 579-66-8 ]
  • [ 455-14-1 ]
  • [ 1616514-80-7 ]
  • [ 1616514-86-3 ]
Reference: [1] Organic and Biomolecular Chemistry, 2014, vol. 12, # 27, p. 4952 - 4963
  • 12
  • [ 455-14-1 ]
  • [ 7657-08-1 ]
Reference: [1] Journal of Organic Chemistry, 1977, vol. 42, p. 2426 - 2431
  • 13
  • [ 108-22-5 ]
  • [ 455-14-1 ]
  • [ 713-45-1 ]
Reference: [1] Green Chemistry, 2018, vol. 20, # 6, p. 1290 - 1296
[2] Journal of the American Chemical Society, 2015, vol. 137, # 28, p. 8892 - 8895
  • 14
  • [ 1616514-65-8 ]
  • [ 455-14-1 ]
  • [ 24549-06-2 ]
  • [ 1616514-73-8 ]
  • [ 1616514-79-4 ]
  • [ 1616514-85-2 ]
YieldReaction ConditionsOperation in experiment
18% With hydrogenchloride In ethanol for 2 h; Inert atmosphere; Reflux General procedure: To a round bottom flask were charged with an N,N′-diaryl hydrazine (9 or 15, 1 mmol), 95percent ethanol (10 mL), and conc. HCl (0.5 mL) under nitrogen at room temperature. The reaction mixture was refluxed for 2 h, then cooled to room temperature, neutralized with solid NaHCO3, filtered, concentrated. The residue was purified by flash column chromatography.
Reference: [1] Organic and Biomolecular Chemistry, 2014, vol. 12, # 27, p. 4952 - 4963
[2] Tetrahedron, 2016, vol. 72, # 17, p. 2186 - 2195
  • 15
  • [ 455-13-0 ]
  • [ 1639128-65-6 ]
  • [ 455-14-1 ]
  • [ 24549-06-2 ]
  • [ 1616514-73-8 ]
  • [ 1616514-85-2 ]
Reference: [1] Organic and Biomolecular Chemistry, 2014, vol. 12, # 27, p. 4952 - 4963
  • 16
  • [ 455-14-1 ]
  • [ 2991-42-6 ]
Reference: [1] Liebigs Annales, 1997, # 1, p. 141 - 154
[2] Journal of Medicinal Chemistry, 2013, vol. 56, # 13, p. 5261 - 5274
  • 17
  • [ 455-14-1 ]
  • [ 32857-62-8 ]
Reference: [1] Patent: CN107417509, 2017, A,
  • 18
  • [ 455-14-1 ]
  • [ 830-43-3 ]
Reference: [1] Liebigs Annales, 1997, # 1, p. 141 - 154
  • 19
  • [ 455-14-1 ]
  • [ 6526-08-5 ]
Reference: [1] Synlett, 2006, # 1, p. 65 - 68
  • 20
  • [ 455-14-1 ]
  • [ 3282-30-2 ]
  • [ 25617-34-9 ]
YieldReaction ConditionsOperation in experiment
98% With triethylamine In dichloromethane EXAMPLE 163 STR185 Step 1.
Preparation of N-(4-trifluoromethylphenyl)-2,2-dimethylpropanamide.
A solution of dichloromethane (200 mL), 4-aminobenzotrifluoride (32.0 g, 199 mmol) and triethylamine (40 g, 396 mmol) was cooled to 0° C. under a dry nitrogen atmosphere.
Trimethylacetyl chloride (32.9 g, 273 mmol) was added drop-wise over 2 hours, maintaining the temperature below 10° C.
After the addition, the contents were allowed to warm to room temperature for 2 hours.
The reaction was washed with water (2*200 mL), saturated ammonium chloride solution (2*200 mL), dried over sodium sulfate and filtered.
The solvent was removed in vacuo to afford a white solid, N-(4-trifluoromethylphenyl)-2,2-dimethylpropanamide (48.0 g, 98percent): mp 157-159° C. 1 H NMR (CDCl3 /300 MHz) 7.61 (ab, 4H, J=8.7, Δν=28.6 Hz), 7.47 (br s, 1H), 1.33 (s, 9H). ESHRMS m/z 246.1123 (M+H+, Calc'd 246.1106). Anal. Calc'd for C12 H14 F3 NO: C, 58.77; H, 5.75; N, 5.71. Found: C, 58.28; H, 5.79; N, 5.65.
98% With triethylamine In dichloromethane Step 1.
Preparation of N-(4-trifluoromethylphenyl)-2,2-dimethylpropanamide
A solution of dichloromethane (200 mL), 4-aminobenzotrifluoride (32.0 g, 199 mmol) and triethylamine (40 g, 396 mmol) was cooled to 0° C. under a dry nitrogen atmosphere.
Trimethylacetyl chloride (32.9 g, 273 mmol) was added drop-wise over 2 hours, maintaining the temperature below 10° C.
After the addition, the contents were allowed to warm to room temperature for 2 hours.
The reaction was washed with water (2*200 mL), saturated ammonium chloride solution (2*200 mL), dried over sodium sulfate and filtered.
The solvent was removed in vacuo to afford a white solid, N-(4-trifluoromethylphenyl)-2,2-dimethylpropanamide (48.0 g, 98percent): mp 157-159° C. 1 H NMR (CDCl3 /300 MHz) 7.61 (ab, 4H, J=8.7, Δν=28.6 Hz), 7.47 (br s, 1H), 1.33 (s, 9H). ESHRMS m/z 246.1123 (M+H+, Calc'd 246.1106). Anal. Calc'd for C12 H14 F3 NO: C, 58.77; H, 5.75; N, 5.71. Found: C, 58.28; H, 5.79; N, 5.65.
97% With pyridine In dichloromethane EXAMPLE 65
4'-Trifluoromethyl-2,2-dimethylpropionanilide
To a stirred solution of 4-trifluoromethylaniline (25 g, 0.155 mol) and pyridine (62 ml, 0.775 mol) in dichloromethane (300 ml) cooled to 0° C. under nitrogen was added dropwise pivaloyl chloride (19 ml, 0.155 mol).
The reaction mixture was stirred at room temperature for 3.5 hr, then diluted with dichloromethane (300 ml).
The resulting solution was washed sequentially with 1N aqueous hydrochloric acid solution (2*), saturated aqueous sodium bicarbonate solution, water and brine, dried (anhydrous sodium sulfate)and concentrated in vacuo to yield the title compound as a white solid (37 g, 97percent yield).
1 H NMR (250 MHz, CDCl3) δ 1.33 (s, 9H); 7.74 (b, 1H); 7.57 (d, 2H); 7.67 (d, 2H).
Reference: [1] Patent: US6034256, 2000, A,
[2] Patent: US6077850, 2000, A,
[3] Patent: US5770594, 1998, A,
[4] Journal of Labelled Compounds and Radiopharmaceuticals, 2010, vol. 53, # 3, p. 141 - 147
[5] Journal of Medicinal Chemistry, 1988, vol. 31, # 6, p. 1215 - 1220
[6] Patent: US2005/54627, 2005, A1, . Location in patent: Page/Page column 38
[7] Patent: US2005/54626, 2005, A1, . Location in patent: Page/Page column 34
[8] European Journal of Medicinal Chemistry, 2010, vol. 45, # 7, p. 2726 - 2732
[9] Journal of Fluorine Chemistry, 2010, vol. 131, # 7, p. 800 - 804
[10] Angewandte Chemie - International Edition, 2015, vol. 54, # 47, p. 14103 - 14107[11] Angew. Chem., 2015, vol. 127, # 47, p. 14309 - 14313,5
[12] Angewandte Chemie - International Edition, 2018, vol. 57, # 29, p. 9108 - 9112[13] Angew. Chem., 2018, vol. 130, p. 9246 - 9250,5
  • 21
  • [ 455-14-1 ]
  • [ 630-19-3 ]
  • [ 25617-34-9 ]
Reference: [1] ACS Catalysis, 2016, vol. 6, # 12,
  • 22
  • [ 455-14-1 ]
  • [ 75-84-3 ]
  • [ 25617-34-9 ]
Reference: [1] ACS Catalysis, 2016, vol. 6, # 12,
  • 23
  • [ 455-14-1 ]
  • [ 598-98-1 ]
  • [ 25617-34-9 ]
Reference: [1] Synlett, 2001, # 9, p. 1485 - 1487
[2] Patent: WO2004/58260, 2004, A1, . Location in patent: Page/Page column 14
  • 24
  • [ 455-14-1 ]
  • [ 3282-30-2 ]
  • [ 144-55-8 ]
  • [ 25617-34-9 ]
Reference: [1] Patent: US4762838, 1988, A,
  • 25
  • [ 455-14-1 ]
  • [ 616-38-6 ]
  • [ 22864-65-9 ]
YieldReaction ConditionsOperation in experiment
74% With 1,8-diazabicyclo[5.4.0]undec-7-ene In 1-methyl-pyrrolidin-2-one at 250℃; for 0.2 h; Flow reactor General procedure: Selective N-monomethlyation reactions were performed in a Vapourtec E-series continuous flow system equipped with a high temperature tube reactor (10 mL, stainless steel, 0.03'' i.d., Fig. 2 ) and a membrane back pressure regulator (Zaiput). Stock solutions of aniline (20 mmol, 1.0 equiv, 2 M), DMC (5.05 mL, 60 mmol, 3.0 equiv, 6 M), and DBU (4.47 mL, 30 mmol, 1.5 equiv, 3 M) were prepared in oven-dried 10 mL volumetric flasks using NMP as the solvent. The solutions were transferred to screw-thread vials with septum caps and reagents were pumped directly from the vials. After the high temperature coiled tube reactor was heated to 250 °C, peristaltic pumps (Vapourtec V-3) were used to pump the reactant solutions into the system (0.277 mL/min each for a 12 min residence time). The solutions were mixed with a cross-mixer (0.4″ i.d.), passed though the high temperature coiled tube reactor. Upon exiting the reactor, the reaction stream was passed through a short segment of stainless steel tubing to enable the reaction to cool and then exited the system by passage through the back pressure regulator (Note: PFA fittings should not be used at the exit of the reactor as they will deform due to the high temperature of the reaction stream and cause leaks in the system. Stainless steel connectors and tubing (12'') were used in our system.). After the flow system was equilibrated for 18 min, the product stream was collected for 5 min (2.77 mmol of aniline). The crude mixture was dissolved in ethyl acetate and washed with brine. The combined organic layers were dried over magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by column chromatography (Biotage 25 g Ultra-sil, 3–15percent ethyl acetate in hexanes) to afford the desired product.
Reference: [1] Tetrahedron, 2018, vol. 74, # 25, p. 3124 - 3128
  • 26
  • [ 455-14-1 ]
  • [ 13061-96-6 ]
  • [ 22864-65-9 ]
YieldReaction ConditionsOperation in experiment
70% With pyridine; copper diacetate In 1,4-dioxane for 6 h; Reflux Intermediate 1: N-Methyl-4-(trifluoromethyl) aniline To a mixture of 4-trifluoromethylaniline (196 mg, 1.2 mmol), copper acetate (550 mg, 3.0 mmol) and pyridine (0.34 mL, 4.2 mmol) in dioxane (6 mL) was added methylboronic acid (181 mg, 3.0 mmol, Aldrich, Catalog number: 165335). The mixture was heated with stirring under reflux for 6 hours. The resulting mixture was filtered. The filtrate was concentrated under vacuum and purified by column chromatography to afford N-methyl-4-(trifluoromethyl)-aniline (150 mg, 70 percent). MS obsd. (ESI+) [(M+H)+]: 176
Reference: [1] Organic Letters, 2009, vol. 11, # 8, p. 1677 - 1680
[2] Patent: WO2016/23877, 2016, A1, . Location in patent: Page/Page column 25
  • 27
  • [ 67-56-1 ]
  • [ 455-14-1 ]
  • [ 22864-65-9 ]
Reference: [1] Advanced Synthesis and Catalysis, 2017, vol. 359, # 24, p. 4278 - 4283
[2] Inorganic Chemistry, 2015, vol. 54, # 11, p. 5079 - 5084
  • 28
  • [ 329-17-9 ]
  • [ 455-14-1 ]
  • [ 22864-65-9 ]
Reference: [1] Chemical Communications, 2000, # 5, p. 393 - 394
  • 29
  • [ 592489-19-5 ]
  • [ 455-14-1 ]
  • [ 623-08-5 ]
  • [ 22864-65-9 ]
Reference: [1] Bulletin of the Chemical Society of Japan, 2003, vol. 76, # 5, p. 1063 - 1070
  • 30
  • [ 455-14-1 ]
  • [ 22864-65-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 10, p. 2621 - 2627
  • 31
  • [ 455-14-1 ]
  • [ 149-73-5 ]
  • [ 22864-65-9 ]
Reference: [1] Journal of Medicinal Chemistry, 1991, vol. 34, # 11, p. 3295 - 3301
  • 32
  • [ 455-14-1 ]
  • [ 598-21-0 ]
  • [ 3823-19-6 ]
Reference: [1] Journal of Medicinal Chemistry, 2016, vol. 59, # 24, p. 11148 - 11160
[2] Journal of the American Chemical Society, 1970, vol. 92, p. 2114 - 2118
[3] RSC Advances, 2017, vol. 7, # 54, p. 34005 - 34011
  • 33
  • [ 22118-09-8 ]
  • [ 455-14-1 ]
  • [ 3823-19-6 ]
Reference: [1] Journal of Medicinal Chemistry, 2014, vol. 57, # 24, p. 10544 - 10550
[2] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 5, p. 1985 - 1988
[3] ACS Medicinal Chemistry Letters, 2016, vol. 7, # 3, p. 235 - 239
  • 34
  • [ 455-14-1 ]
  • [ 372-09-8 ]
  • [ 24522-30-3 ]
YieldReaction ConditionsOperation in experiment
95%
Stage #1: With 4-methyl-morpholine In tetrahydrofuran at 0 - 10℃; for 1 h; Industry scale
Stage #2: With isopropyl chloroformate In tetrahydrofuran at 0 - 10℃; for 2 - 3 h; Industry scale
Example 1
Preparation of 4-trifluoromethyl cyanoacetoanilide (compound (IV))
In 700 L of tetrahydrofuran, 63.4 kg of cyanoacetic acid was dissolved with stirring in nitrogen atmosphere at room temperature.
This solution was cooled to 0 to 10°C, and then N-methylmorpholine was added dropwise with stirring at the same temperature in about an hour.
Then, 100.0 kg of 4-trifluoromethylaniline was added dropwise.
To this reaction mixture, 91.3kg of isopropyl chlorocarbonate was added dropwise with stirring at the same temperature in about an hour.
Further, the stirring was continued for 1 to 2 hours.
After the reaction was finished, 200 L of water was added to the reaction mixture, which was stirred and then allowed to stand for separation.
An organic layer (upper layer) was washed with 16.7 percent brine, and then 400 L of isopropyl alcohol was added thereto, which was concentrated under reduced pressure until the liquid amount became 400 L.
To the condensed solution, 400 L of isopropyl alcohol was added, which was concentrated again under reduced pressure until the liquid amount became 400 L.
To the condensed solution, 100 L of isopropyl alcohol was added at 20 to 30°C with stirring, and then 500 L of water was added dropwise in about an hour.
Then, the stirring was further continued for an hour at the same temperature.
This mixture was cooled to 0 to 10°C with stirring, and then stirred at the same temperature for an hour.
Precipitated crystals were collected by filtration and dried, to give 134.5 kg of the title compound (IV) in a yield of 95.0 percent.
88.15% With dicyclohexyl-carbodiimide In ethyl acetate at 25 - 30℃; for 2 h; Inert atmosphere In a 500-ml., four-necked, round-bottomed flask fitted with a mechanical stirrer, a 125-ml dropping funnel, and a thermometer were placed 8.34g. (0.098 moles) of cyanoacetic acid (7) and 165- ml., of ethyl acetate and the mixture was stirred for 10 minutes under nitrogen atmosphere and then added 10.0 g. ( 0.62 moles) of 4-trifluoromethyl aniline (3). From a clean dropping funnel 14.1 g. (0.068 moles, dissolved in ethyl acetate 85mL) of dicyclohexylcarbodiimide was added dropwise over a period of about 1 hour at the same temperature. The reaction mixture was stirred for additional 1.0 hour at 25-30°C. After completion of the reaction precipitated urea was filtered and slurry washed successively with two 50-ml. portions of ethyl acetate and filtered. The organic extracts were combined and washed successively with two 50-ml. portions of 5percent sodium bicarbonate solution, 25-ml.of 5percent hydrochloric acid solution, and again with 50-ml. of 5percent sodium chloride solution. Separated organic layer was evaporated under reduced pressure to yield solid material. To the solid 170-ml isopropyl alcohol was added and the mixture was heated to70-75°C, obtained clear solution and filtered. The filtrate was concentrated to 10 volumes and cooled to 15-20°C. The separated product was filtered and dried in a vacuum oven. Yield =12.5. g (88.15percent), HPLC Purity: 99.6percent
Reference: [1] Patent: EP1609778, 2005, A1, . Location in patent: Page/Page column 5; 8-9
[2] Patent: WO2017/103942, 2017, A1, . Location in patent: Page/Page column 5; 7
[3] Journal of Medicinal Chemistry, 1996, vol. 39, # 23, p. 4608 - 4621
[4] Journal of Medicinal Chemistry, 2017, vol. 60, # 11, p. 4626 - 4635
[5] Journal of Medicinal Chemistry, 1991, vol. 34, # 11, p. 3295 - 3301
[6] Journal of Labelled Compounds and Radiopharmaceuticals, 2003, vol. 46, p. S119 - S119
[7] Patent: US5714514, 1998, A,
[8] Bioorganic and Medicinal Chemistry, 2009, vol. 17, # 3, p. 1079 - 1087
[9] Patent: EP1609778, 2005, A1, . Location in patent: Page/Page column 5; 10
[10] Journal of Heterocyclic Chemistry, 2011, vol. 48, # 4, p. 901 - 906
  • 35
  • [ 455-14-1 ]
  • [ 16130-58-8 ]
  • [ 24522-30-3 ]
Reference: [1] Helvetica Chimica Acta, 1998, vol. 81, # 7, p. 1319 - 1328
[2] Journal of Medicinal Chemistry, 2009, vol. 52, # 9, p. 2683 - 2693
  • 36
  • [ 455-14-1 ]
  • [ 105-56-6 ]
  • [ 24522-30-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 5, p. 1369 - 1375
[2] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 4, p. 1195 - 1198
[3] Indian Journal of Heterocyclic Chemistry, 2012, vol. 21, # 3, p. 225 - 228
  • 37
  • [ 455-14-1 ]
  • [ 36140-83-7 ]
  • [ 24522-30-3 ]
Reference: [1] Archiv der Pharmazie, 2018, vol. 351, # 7,
  • 38
  • [ 887144-94-7 ]
  • [ 455-14-1 ]
  • [ 367-71-5 ]
YieldReaction ConditionsOperation in experiment
82% With potassium carbonate; nickel(II) hydroxide In dimethyl sulfoxide at 35℃; for 2 h; In the preparation method of the trifluoromethyl aromatic amine of the present embodiment, the aromatic amine is p-trifluoromethylaniline, and other reactions and post-treatment processes are the same as in the embodiment 28.
The preparation method of the trifluoromethyl aromatic amine of the present embodiment, the aromatic amine is aniline, and the nickel compound is nickel hydroxide.The base is potassium carbonate, and the reaction process parameters are: 1-trifluoromethyl-1,2-phenyliodo-3(H)-one (0.5 mmol, 1.0 eq).Aromatic amine (1.5 mmol, 3.0 eq), nickel hydroxide 10 molpercent, potassium carbonate (1.5 mmol, 3.0 eq),DMSO (2 mL) was reacted at 35 ° C for 2 h, and the other reactions and workup procedures were the same as in Example 1.
Reference: [1] Organic Letters, 2018, vol. 20, # 13, p. 3732 - 3735
[2] Patent: CN108503552, 2018, A, . Location in patent: Paragraph 0142-0146
  • 39
  • [ 455-14-1 ]
  • [ 2314-97-8 ]
  • [ 367-71-5 ]
YieldReaction ConditionsOperation in experiment
89% With fac-tris(2-phenylpyridinato-N,C2')iridium(III); potassium carbonate In 1,2-dichloro-ethane at 20℃; for 24 h; Inert atmosphere; Schlenk technique; Irradiation General procedure: A 25 mL of Schlenk tube equipped with a magnetic stir bar were charged with aniline (1.2 mmol, 3.0 equiv) or heterocycles (0.8 mmol, 2.0 equiv), K2CO3 (0.8 mmol, 2.0 equiv) and fac-Ir(ppy)3 (2.6 mg, 0.004 mmol, 1 mol percent), under air. The vessel was evacuated and backfilled with Ar (3 times), CF3I stock solution (0.56 mL, 0.71 mmol/mL in 1,2-chloroethane or 0.36 mL, 1.11 mmol/mL in DMSO, 1.0 equiv), anhydrous 1,2-dichloroethane (3 mL) were then added. The tube was screw capped and stirred at room temperature under irradiation of blue LEDs (12 W) for 24 hours. The reaction S15 mixture was filtered through a pad of Celite and washed with ethyl acetate (3×5 mL). The filtrate was concentrated. The residue was subjected to column chromatography on silica gel to afford the pure product.
Reference: [1] Tetrahedron Letters, 2017, vol. 58, # 41, p. 3939 - 3941
  • 40
  • [ 455-14-1 ]
  • [ 2926-29-6 ]
  • [ 367-71-5 ]
Reference: [1] Journal of Organic Chemistry, 2014, vol. 79, # 19, p. 8984 - 8989
  • 41
  • [ 455-14-1 ]
  • [ 128796-39-4 ]
YieldReaction ConditionsOperation in experiment
62%
Stage #1: With hydrogenchloride; sodium nitrite In methanol; water at 0 - 5℃; for 0.5 h;
Stage #2: With tetrahydroxydiboron In methanol; water at 20℃; for 1 h;
General procedure: To a solution of arylamine (0.5 mmol, 1.0 equiv) in MeOH(1.0 mL) was added HCl (0.5 mL, 1.5 mmol, 3.0 equiv), followed by H2O (0.5 ml). This mixture was stirred 2 min,and the NaNO2 solution (0.25 mL) was then added. The NaNO2 solution was prepared by dissolving 35 mg ofNaNO2 in H2O (0.25 mL). This mixture was stirred 30 minat 0–5 °C, followed by HCl (135 mg, 1.5 mmol, 3.0 equivalents) in MeOH (1.0 mL). This mixture was stirred 60min. H2O (10 mL) was added to reaction mixture, then extracted with CH2Cl2 (50 mL, 3×). The combined organic layer was dried over Na2SO4, followed by evaporation to give the products.
Reference: [1] Synlett, 2014, vol. 25, # 11, p. 1577 - 1584
  • 42
  • [ 455-14-1 ]
  • [ 24279-39-8 ]
  • [ 39885-50-2 ]
YieldReaction ConditionsOperation in experiment
98% With chlorine In chlorobenzene at 110℃; for 6.5 h; 12 140 kg of pure monochlorobenzene are charged to a 20 m3 jacketed reactor rendered inert with nitrogen. The solvent heel is subsequently brought to 110C by heating the jacket. The reactor is subsequently fed with a 70percent solution of para-trifluoromethylaniline in monochlorobenzene at a flow rate of 792 kg/h for 6 h 30 and with Cl at a flow rate of 488 kg/h. The temperature is maintained at 110C by cooling the jacket. Once feeding is complete, the residual content of para-trifluoromethylaniline or of monochloro derivative is monitored. If one of these compounds remains, it is then advisable to adjust the amount of chlorine in order to consume the residual product. At the end of the reaction, the monochlorobenzene is distilled off by placing the reactor under gradually increasing vacuum through a distillation column. After removal of the solvent, the 2,6-dichloro-para-trifluoromethylaniline is cooled to 60C before emptying the reactor to the storage tank.
Reference: [1] Patent: WO2004/37766, 2004, A2, . Location in patent: Page 4
  • 43
  • [ 455-14-1 ]
  • [ 39885-50-2 ]
Reference: [1] Organic Letters, 2016, vol. 18, # 9, p. 1976 - 1979
[2] Synthesis, 1985, # 6/7, p. 669 - 670
  • 44
  • [ 67305-24-2 ]
  • [ 455-14-1 ]
  • [ 75706-12-6 ]
YieldReaction ConditionsOperation in experiment
86% With sodium hydrogencarbonate In N,N-dimethyl acetamide; toluene c)
4-Trifluoromethylaniline (5.75 g, 35.7 mm) was dissolved in a mixture of NaHCO3 (3.16 g, 37.6 mm), N,N-dimethylacetamide (0.7 ml, 7.5 mm) and toluene (70 ml).
The mixture was warmed to 40° C. and 5-methylisoxazole-4-carboxylic acid chloride (5 g, 34.4 mm) was added dropwise over 20 min.
The mixture was stirred at this temperature for another 3 h. and then it was heated to reflux temperature.
The hot mixture was washed with water (3*10 ml).
The organic phase was allowed to cool to ambient temperature, which induced leflunomide to precipitate as a white powder.
The powder was isolated by filtration and then dried at 60° C. to give leflunomide (8.0 g, 86percent) in 99.5percent purity.
Reference: [1] Farmaco, 1991, vol. 46, # 6, p. 789 - 802
[2] Patent: US2002/22646, 2002, A1,
[3] Chemistry - A European Journal, 2014, vol. 20, # 31, p. 9514 - 9518
[4] Patent: US2002/22646, 2002, A1,
[5] Patent: US5494911, 1996, A,
[6] Patent: US5504084, 1996, A,
[7] Patent: US5547971, 1996, A,
[8] Patent: US5519042, 1996, A,
[9] Patent: US4284786, 1981, A,
[10] Patent: WO2016/203410, 2016, A1, . Location in patent: Page/Page column 15; 16; 19
  • 45
  • [ 455-14-1 ]
  • [ 75706-12-6 ]
YieldReaction ConditionsOperation in experiment
62.34%
Stage #1: With thionyl chloride In toluene at 25 - 70℃; for 6 h;
Stage #2: at 0 - 30℃; for 6 h;
N-(4'-trifluoromethyIp)-5-methylisoxazole-4-carboxamide:5-Methylisoxazole~4-carboxylic acid 25.0 g (0.197 mol) was taken in toluene (312.5 ml), heated to reflux arid 62.5 ml toluene was distilled off. The solution was cooled to 25-30 0C. To this solution N, N-Dimethylformamide (0.16 ml) and thionyl chloride 25.68 g (0.216 mol) was added at 25-30 C and heated to 65 to 70 0C for 6 hours. Then the reaction mass was cooled to 0 0C and 4-trifluoromethylaniline 30.07 g (0.199 mol) was added drop wise at this temperature. The resulted reaction mixture was stirred at the same temperature for 2 hours, allowed to come to 25-30 0C and stirred for 4 hours. Water (125 ml) was added to the ' reaction mixture and stirred for 2 hours. The solid was separated out, which was filtered and washed with water (250 ml), dried under vacuum at 80 0C to obtain 40.25 g off white solid which was purified with toluene to give 33.15 g (62.34 percent) leflunomide with 99.9percent HPLC purity and any individual impurity less than 0.1percent.
Reference: [1] Patent: WO2007/86076, 2007, A2, . Location in patent: Page/Page column 5-7
  • 46
  • [ 455-14-1 ]
  • [ 67305-24-2 ]
  • [ 75706-12-6 ]
Reference: [1] Patent: US2002/22646, 2002, A1,
  • 47
  • [ 455-14-1 ]
  • [ 75706-12-6 ]
Reference: [1] Patent: US5547970, 1996, A,
  • 48
  • [ 455-14-1 ]
  • [ 69409-98-9 ]
Reference: [1] Journal of Organic Chemistry, 1985, vol. 50, # 23, p. 4576 - 4582
  • 49
  • [ 455-14-1 ]
  • [ 2923-56-0 ]
Reference: [1] Journal of Organic Chemistry, 1995, vol. 60, # 8, p. 2411 - 2422
[2] Journal of Agricultural and Food Chemistry, 2014, vol. 62, # 2, p. 381 - 390
[3] Advanced Synthesis and Catalysis, 2014, vol. 356, # 7, p. 1571 - 1576
[4] Advanced Synthesis and Catalysis, 2015, vol. 357, # 4, p. 761 - 766
[5] Journal of the Chinese Chemical Society, 2018, vol. 65, # 5, p. 538 - 547
  • 50
  • [ 455-14-1 ]
  • [ 163444-17-5 ]
YieldReaction ConditionsOperation in experiment
97% With Iodine monochloride In methanol; dichloromethane at 0 - 20℃; Step 2
2-Iodo-4-(trifluoromethyl)aniline
A 500 mL 3-necked round bottom flask was charged with 4-(trifluoromethyl)aniline (22.5 g, 0.14 mol) and MeOH (100 mL).
To the above was added dropwise a solution of IC1 (25 g, 0.15 mol) in CH2Cl2 (100 mL) at 0° C.
The resulting mixture was stirred at room temperature for 1 h.
Reaction progress was monitored by TLC (EtOAc/Petroleum ether=1:10, Rf=0.5). Work-up:
the mixture was concentrated in vacuo.
The residue was re-dissolved in CH2Cl2, washed with water, dried over anhydrous Na2SO4 and concentrated in vacuo, to give 37.8 g (97percent) of the product. 1H NMR (300 MHz, CDCl3) δ: 7.86 (d, J=1.2 Hz, 1H), 7.36 (dd, J=8.4, 1.8 Hz, 1H), 6.73 (d, J=8.7 Hz, 1H), 4.41 (br, 2H).
97% With Iodine monochloride In methanol; dichloromethane at 0 - 20℃; for 1 h; A 500 mL 3-necked round bottom flask was charged with 4- (trifluoromethyl)aniline (22.5 g, 0.14 mol) and MeOH (100 mL). To the above was added dropwise a solution of ICl (25 g, 0.15 mol) in CH2C12 (100 mL) at 0 °C. The resulting mixture was stirred at room temperature for 1 h. Reaction progress was monitored by TLC (EtO Ac/Petroleum ether = 1 : 10, Rf = 0.5). Work-up: the mixture was concentrated in vacuo. The residue was re-dissolved in CH2C12, washed with water, dried over anhydrous Na2S04 and concentrated in vacuo, to give 37.8 g (97percent) of the product. *H NMR (300 MHz, CDC13) δ: 7.86 (d, J = 1.2 Hz, 1H), 7.36 (dd, J = 8.4, 1.8 Hz, 1H), 6.73 (d, J = 8.7 Hz, 1H), 4.41 (br, 2H).
89% With N-iodo-succinimide; [bis(trifluoromethanesulfonyl)imidate](triphenylphosphine)gold(I) In 1,2-dichloro-ethane; toluene at 85℃; for 14 h; General procedure: To a stirred solution of the substrate (1 mmol) in CH2Cl2 or (CH2Cl)2 (0.1 M) were added Ph3PAuNTf2 (0.025 mmol, 19 mg; complex Ph3PAuNTf2 toluene, 2:1) followed by N-iodosuccinimide (1.1 mmol, 248 mg). The resulting solution was stirred at r.t. or under reflux until complete conversion of the starting material. After removal of the solvent under reduced pressure, the crude material was purified by flash column chromatography using different gradients of hexanes and EtOAc to obtain the pure desired products.
75% With N,N,N-trimethylbenzenemethanaminium dichloroiodate; calcium carbonate In methanol; dichloromethane at 20℃; for 24 h; PREPARATION 4; 2-Iodo-4-(trifluoromethyl)aniline; A solution of 5 g (31 mM) of 4-(trifluoromethyl)aniline in 90 ml of methanol and 30 ml of dichloromethane is prepared and 3.56 g (35.6 mM) of calcium carbonate are added. 14.9 g (42.7 mM) of trimethylbenzylammonium dichloroiodide are then added in portions at room temperature, with stirring. The reaction medium is stirred for 24 hours at room temperature and then filtered to remove the mineral salts. The filtrate is concentrated under reduced pressure and the crude product is purified by chromatography on silica gel using a cyclohexane/ethyl acetate mixture (8/2; v/v) as the eluent to give 6.65 g of the expected compound in the form of an orange oil (yield=75percent).1H NMR (CDCl3, 300 MHz) δ=5.0 (s, 2H), 6.82 (d, J=5.5 Hz, 1H), 7.38 (dd, J=5.5 Hz, 1.3 Hz, 1H), 7.79 (d, J=1.3 Hz, 1H).
70% With Iodine monochloride In methanol; dichloromethane at 20℃; To a solution of 4-(trifluoromethyl)benzenamine (10.0 g, 0.0617 mol) in dry methanol (200 ml) was added iodine monochloride (10.49 g, 0.148 mol) in dry MDC (40 ml) at RT slowly. Reaction mixture was stirred at RT over night. The reaction mixture was concentrated, water was added and extracted with ethyl acetate (2.x.100 ml). The organic layer was washed with water, brine (2.x.50 ml), dried over Na2SO4 and concentrated. The crude product was purified by column chromatography using 6percent ethyl acetate in pet-ether to get 2-iodo-4-(trifluoromethyl)benzenamine (12.5 g, 70percent) as pale yellow liquid. 1H NMR (400 MHz, CDCl3) δ 4.42 (bs, 2H), 6.75 (d, 1H), 7.38 (d, 1H), 7.87 (s, 1H).
61% With iodine; silver sulfate In ethanol at 20℃; for 18 h; Method DSynthesis of substituted 2-(1 H-indol-3-yl)ethanamineStep I: substituted 2-iodo-aniline Iodine (1 eq) was added to a stirred mixture of silver sulphate (1 eq) and an aniline (1 eql) in ethanol (6.21 mL/mmol). The reaction mixture was then stirred at room temperature for 18 hours and filtered over celite. The solution was concentrated under reduced pressure and the residue was partitioned between ethyl acetate and a saturated aqueous solution of sodium thiosulphate. The organic layer was washed with brine, dried with magnesium sulphate and concentrated under reduced pressure. The crude residue was purified by flash chromatography on silica gel to yield a substituted 2-iodo-aniline; INTERMEDIATE 10 - PREPARATION of 2-iodo-4-(trifluoromethyl)aniline. 2-iodo-4-(trifluoromethyl)aniline was prepared according to method D Step I with iodine (1.58 g; 6.21 mmol), silver sulphate (1.94 g; 6.21 mmol) and 4-(trifluoromethyl)aniline (0.8 mL; 6.21 mmol) in ethanol (40 mL). The crude residue was purified by flash chromatography on silica gel (eluent 2 to 40 percent ethyl acetate in heptane) to afford 1.08 g (61 percent) of 2-iodo-4-(trifluoromethyl)aniline as a red oil.1 H NMR (DMSO-d6) δ 7.80 (s, 1 H), 7.38 (d, 1 H), 6.82 (d, 2H), 5.93 (s, 2H).
61% With iodine; silver sulfate In ethanol at 20℃; for 18 h; INTERMEDIATE 40 - PREPARATION of 2-lodo-4-(trifluoromethyl)aniline. Iodine (1.58 g; 6.21 mmol) was added to a stirred mixture of silver sulphate (1.94 g; 6.21 mmol) and 4-(trifluoromethyl)aniline (0.8 mL; 6.21 mmol) in ethanol (40 mL). The reaction mixture was then stirred at room temperature for 18 hours and filtered over celite. The volatiles were removed under reduced pressure and the residue was partitioned between ethyl acetate and a saturated aqueous solution of sodium thiosulfate. The organic layer was washed with brine, dried and concentrated under reduced pressure. The crude residue was purified by flash chromatography on silica gel (eluent 2 to 40 percent ethyl acetate in heptane) to afford 1.08 g (61 percent) of the title compound as a red oil.1 H NMR (DMSO-d6) δ 7.80 (s, 1 H), 7.38 (d, 1 H), 6.82 (d, 2H), 5.93 (s, 2H).
61% With iodine; silver sulfate In ethanol at 20℃; for 18 h; Iodine (1.58 g; 6.21 mmol) was added to a stirred mixture of silver sulphate (1.94 g; 6.21 mmol) and 4-(trifluoromethyl)aniline (0.8 mL; 6.21 mmol) in ethanol (40 mL). The reaction mixture was then stirred at room temperature for 18 hours and filtered over celite. The volatiles were removed under reduced pressure and the residue was partitioned between ethyl acetate and a saturated aqueous solution of sodium thiosulfate. The organic layer was washed with brine, dried and concentrated under reduced pressure. The crude residue was purified by flash chromatography on silica gel (eluent 2 to 40percent ethyl acetate in heptane) to afford 1.08 g (61percent) of the title compound as a red oil. [0628] 1H NMR (DMSO-d6) δ 7.80 (s, 1H), 7.38 (d, 1H), 6.82 (d, 2H), 5.93 (s, 2H).
61% With iodine; silver sulfate In ethanol at 20℃; for 18 h; Iodine (1 eq) was added to a stirred mixture of silver sulphate (1 eq) and an aniline (1 eql) in ethanol (6.21 mL/mmol). The reaction mixture was then stirred at room temperature for 18 hours and filtered over celite. The solution was concentrated under reduced pressure and the residue was partitioned between ethyl acetate and a saturated aqueous solution of sodium thiosulphate. The organic layer was washed with brine, dried with magnesium sulphate and concentrated under reduced pressure. The crude residue was purified by flash chromatography on silica gel to yield a substituted 2-iodo-aniline. 2-iodo-4-(trifluoromethyl)aniline was prepared according to method D Step I with iodine (1.58 g; 6.21 mmol), silver sulphate (1.94 g; 6.21 mmol) and 4-(trifluoromethyl)aniline (0.8 mL; 6.21 mmol) in ethanol (40 mL). The crude residue was purified by flash chromatography on silica gel (eluent 2 to 40percent ethyl acetate in heptane) to afford 1.08 g (61percent) of 2-iodo-4-(trifluoromethyl)aniline as a red oil. [0533] 1H NMR (DMSO-d6) δ 7.80 (s, 1H), 7.38 (d, 1H), 6.82 (d, 2H), 5.93 (s, 2H).
61% With iodine; silver sulfate In ethanol at 20℃; for 18 h; INTERMEDIATE 132 - PREPARATION of 2-iodo-4-(trifluoromethyl)aniline; Iodine (1.58 g; 6.21 mmol) was added to a stirred mixture of silver sulphate (1.94 g; 6.21 mmol) and 4-(trifluoromethyl)aniline (0.8 ml
6.21 mmol) in ethanol (40 ml_). The reaction mixture was then stirred at room temperature for 18 hours and filtered through celite. The volatiles were removed under reduced pressure and the residue was partitioned between ethyl acetate and a saturated aqueous solution of sodium thiosulphate. The organic layer was washed with brine, dried and concentrated under reduced pressure. The crude residue was purified by flash chromatography on silica gel (eluent 2 to 40 percent ethyl acetate in heptane) to afford 1.08 g (61 percent) of 2-iodo-4-(trifluoromethyl)aniline as a red oil. 1H NMR (DMSO-de) δ 7.80 (s, 1 H), 7.38 (d, 1 H), 6.82 (d, 2H), 5.93 (s, 2H)
2.3 g With iodine; silver sulfate In ethanol at 20℃; for 1 h; A mixture of 2.5 g of 4-trifluoromethylaniline, 3.9 g of iodine, 4.8 g of silver (I) sulfate, and 300 ml of ethanol was stirred for 1 hour at room temperature. The reaction mixture was filtered through celite, and the filtrate was concentrated under reduced pressure. The residues were subjected to silica gel column chromatography, thereby obtaining 2.3 g of 2-iodo-4-trifluoromethylaniline.1H-NMR (CDC13) ö: 7.88-7.85 (m, 1H), 7.40-7.35 (m, 1H), 6.74 (d, 1H, J=8.3 Hz), 4.42 (br s, 2H)

Reference: [1] Heterocycles, 2002, vol. 57, # 3, p. 465 - 476
[2] Patent: US2010/120741, 2010, A1, . Location in patent: Page/Page column 91
[3] Patent: WO2011/112731, 2011, A2, . Location in patent: Page/Page column 196
[4] Synthesis, 2004, # 11, p. 1869 - 1873
[5] Synlett, 2014, vol. 25, # 3, p. 399 - 402
[6] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 9, p. 2722 - 2725
[7] Patent: US2008/153816, 2008, A1, . Location in patent: Page/Page column 7
[8] Organic Letters, 2011, vol. 13, # 12, p. 3242 - 3245
[9] Patent: US2005/54626, 2005, A1, . Location in patent: Page/Page column 34
[10] Tetrahedron, 1994, vol. 50, # 25, p. 7343 - 7366
[11] Patent: WO2012/80220, 2012, A1, . Location in patent: Page/Page column 71; 75
[12] Patent: WO2012/80221, 2012, A1, . Location in patent: Page/Page column 84-85
[13] Patent: US2013/274260, 2013, A1, . Location in patent: Paragraph 0627-0628
[14] Patent: US2013/289033, 2013, A1, . Location in patent: Paragraph 0510; 0532-0533
[15] Patent: WO2010/142801, 2010, A1, . Location in patent: Page/Page column 187
[16] Arzneimittel-Forschung/Drug Research, 2000, vol. 50, # 12, p. 1084 - 1092
[17] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 24, p. 4385 - 4388
[18] Organic Letters, 2005, vol. 7, # 10, p. 2043 - 2046
[19] Synlett, 2006, # 1, p. 65 - 68
[20] Journal of Organic Chemistry, 2006, vol. 71, # 18, p. 7079 - 7082
[21] Journal of Organic Chemistry, 2009, vol. 74, # 17, p. 6631 - 6636
[22] Patent: WO2005/13985, 2005, A1, . Location in patent: Page/Page column 47-49
[23] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 5, p. 1351 - 1357
[24] Patent: US2015/289512, 2015, A1, . Location in patent: Paragraph 1208; 1209
[25] Journal of Organic Chemistry, 2016, vol. 81, # 22, p. 10987 - 10999
  • 51
  • [ 455-14-1 ]
  • [ 163444-17-5 ]
  • [ 214400-66-5 ]
Reference: [1] Arzneimittel-Forschung/Drug Research, 2000, vol. 50, # 12, p. 1084 - 1092
  • 52
  • [ 455-14-1 ]
  • [ 162100-55-2 ]
Reference: [1] Journal of Medicinal Chemistry, 1998, vol. 41, # 10, p. 1598 - 1612
  • 53
  • [ 455-14-1 ]
  • [ 100846-24-0 ]
Reference: [1] Heterocycles, 2002, vol. 57, # 3, p. 465 - 476
[2] Heterocycles, 2002, vol. 57, # 3, p. 465 - 476
[3] Journal of Medicinal Chemistry, 1998, vol. 41, # 10, p. 1598 - 1612
  • 54
  • [ 455-14-1 ]
  • [ 87-13-8 ]
  • [ 175203-85-7 ]
Reference: [1] Patent: US6093732, 2000, A,
  • 55
  • [ 455-14-1 ]
  • [ 57946-63-1 ]
YieldReaction ConditionsOperation in experiment
50% With N-Bromosuccinimide In dichloromethane Add 200 mL of distilled CH2Cl 2 and 4- (trifluoromethyl) aniline (20 g, 124.13 mmol) to a two neck flask. Slowly dropwise N-bromosuccinimide (24.3 g, 136.5 mmol) dissolved in CH2Cl2. When the reaction is complete, extract with CH2Cl2. Purification by column separation (EA: Hx = 1: 4) (yield: 50percent)
Reference: [1] Journal of Organic Chemistry, 2018, vol. 83, # 2, p. 930 - 938
[2] Patent: KR2018/50795, 2018, A, . Location in patent: Paragraph 0086; 0087; 0104-0106
[3] Patent: US3946025, 1976, A,
[4] Chinese Journal of Chemistry, 2018, vol. 36, # 9, p. 815 - 818
[5] Patent: US3995042, 1976, A,
  • 56
  • [ 455-14-1 ]
  • [ 72678-19-4 ]
  • [ 57946-63-1 ]
Reference: [1] Tetrahedron, 2009, vol. 65, # 22, p. 4429 - 4439
  • 57
  • [ 455-14-1 ]
  • [ 496946-78-2 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 24, p. 4385 - 4388
[2] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 9, p. 2722 - 2725
[3] Patent: US2015/289512, 2015, A1,
  • 58
  • [ 455-14-1 ]
  • [ 852203-17-9 ]
Reference: [1] Synlett, 2006, # 1, p. 65 - 68
  • 59
  • [ 455-14-1 ]
  • [ 762-42-5 ]
  • [ 123158-31-6 ]
Reference: [1] Journal of Heterocyclic Chemistry, 2012, vol. 49, # 6, p. 1323 - 1331
[2] Organic Letters, 2018, vol. 20, # 7, p. 1893 - 1897
[3] Patent: US5270309, 1993, A,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 455-14-1 ]

Fluorinated Building Blocks

Chemical Structure| 96100-12-8

[ 96100-12-8 ]

3-Amino-5-methylbenzotrifluoride

Similarity: 0.97

Chemical Structure| 328-74-5

[ 328-74-5 ]

3,5-Di(trifluoromethyl)aniline

Similarity: 0.97

Chemical Structure| 368-53-6

[ 368-53-6 ]

5-(Trifluoromethyl)benzene-1,3-diamine

Similarity: 0.95

Chemical Structure| 54396-44-0

[ 54396-44-0 ]

2-Methyl-3-(trifluoromethyl)aniline

Similarity: 0.93

Chemical Structure| 368-71-8

[ 368-71-8 ]

4-(Trifluoromethyl)benzene-1,2-diamine

Similarity: 0.93

Aryls

Chemical Structure| 96100-12-8

[ 96100-12-8 ]

3-Amino-5-methylbenzotrifluoride

Similarity: 0.97

Chemical Structure| 328-74-5

[ 328-74-5 ]

3,5-Di(trifluoromethyl)aniline

Similarity: 0.97

Chemical Structure| 368-53-6

[ 368-53-6 ]

5-(Trifluoromethyl)benzene-1,3-diamine

Similarity: 0.95

Chemical Structure| 54396-44-0

[ 54396-44-0 ]

2-Methyl-3-(trifluoromethyl)aniline

Similarity: 0.93

Chemical Structure| 368-71-8

[ 368-71-8 ]

4-(Trifluoromethyl)benzene-1,2-diamine

Similarity: 0.93

Amines

Chemical Structure| 96100-12-8

[ 96100-12-8 ]

3-Amino-5-methylbenzotrifluoride

Similarity: 0.97

Chemical Structure| 328-74-5

[ 328-74-5 ]

3,5-Di(trifluoromethyl)aniline

Similarity: 0.97

Chemical Structure| 368-53-6

[ 368-53-6 ]

5-(Trifluoromethyl)benzene-1,3-diamine

Similarity: 0.95

Chemical Structure| 54396-44-0

[ 54396-44-0 ]

2-Methyl-3-(trifluoromethyl)aniline

Similarity: 0.93

Chemical Structure| 368-71-8

[ 368-71-8 ]

4-(Trifluoromethyl)benzene-1,2-diamine

Similarity: 0.93

Trifluoromethyls

Chemical Structure| 96100-12-8

[ 96100-12-8 ]

3-Amino-5-methylbenzotrifluoride

Similarity: 0.97

Chemical Structure| 328-74-5

[ 328-74-5 ]

3,5-Di(trifluoromethyl)aniline

Similarity: 0.97

Chemical Structure| 368-53-6

[ 368-53-6 ]

5-(Trifluoromethyl)benzene-1,3-diamine

Similarity: 0.95

Chemical Structure| 54396-44-0

[ 54396-44-0 ]

2-Methyl-3-(trifluoromethyl)aniline

Similarity: 0.93

Chemical Structure| 368-71-8

[ 368-71-8 ]

4-(Trifluoromethyl)benzene-1,2-diamine

Similarity: 0.93